TELA Bio, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from TELA Bio, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Tangible Assets Ratio: Of every $100 the company owns, $98 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. More tangible than 85% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-54.0×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 73% of Healthcare companies in United States.
Cash Locked Ratio
$19For every $100 of sales, $19 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $38 tied up three years earlier.
Less money tied up than 60% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 1/3Sales grew in 3 of the last 3 years; profit grew in 1 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
$14Sales grew 94% in 3 years; of every extra $100 of sales, $14 became extra profit.
Lower than 56% of Healthcare companies in United States.
Asset Productivity Ratio
+94% / +20%In 3 years sales changed by +94% while total assets changed by +20%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
-53.9×Operating cash was negative last year, while some debt falls due within a year.
Lower than 75% of Healthcare companies in United States.
Cash Cushion Ratio
−12%Debt, after subtracting cash, equals 12% of its market value (net debt).
Lower than 79% of Healthcare companies in United States.
Tangible Assets Ratio
98%Of every $100 the company owns, $98 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 85% of Healthcare companies in United States.
Tangible Net Worth Ratio
78%Of every $100 of net worth, $78 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 61% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (11)
TELA Bio, Inc. made a loss over the last year. TELA Bio, Inc. owes $1.27 for every $1 it owns. TELA Bio, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossTELA Bio, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
-2.87TELA Bio, Inc.'s book value is negative (it owes more than it owns), so P/B is not meaningful.
Market cap
$46 MThe total market value of all of TELA Bio, Inc.'s shares at today's price (share price × number of shares), smaller than 75% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
NegativeTELA Bio, Inc.'s net worth is negative ($16 M below zero, balance sheet 30 Jun 2026): it owes more than it owns, so book value per share and P/B are not meaningful.
Owes vs Owns
1.27×TELA Bio, Inc. owes $1.27 for every $1 it owns, so it owes more than it owns, higher than 92% of Healthcare companies in United States.
Dividend yield
NoneTELA Bio, Inc. does not currently pay a dividend.
Revenue growth
+16%Revenue rose 16% in the year to Dec 2025, and grew 25% a year on average over 3 years.
Profit growth
LossTELA Bio, Inc. made a loss in each of the last two years.
Profit margin
-48.4%TELA Bio, Inc. lost $48 for every $100 of revenue.
Interest cover
Not coveredTELA Bio, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net debtTELA Bio, Inc. had $5 M more debt than cash (net debt) at Dec 2025.
Questions
How much does TELA Bio, Inc. owe compared with what it owns?
TELA Bio, Inc. owes $1.27 for every $1 it owns, so it owes more than it owns, higher than 92% of Healthcare companies in United States.
Does TELA Bio, Inc. pay a dividend?
No. TELA Bio, Inc. does not currently pay a dividend.
Is TELA Bio, Inc.'s revenue growing?
Revenue rose 16% in the year to Dec 2025, and grew 25% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.